The experimental study for HFD's mechanism to inhibit Lewis lung cancer in mice

Xue Song,Zhong Meizuo,Liu Wei,Li Jianhuang,Huang Jin

DOI: https://doi.org/10.3969/j.issn.2095-1264.2011.01.009

2011-01-01

Abstract:Objective The purpose of this study is to define whether HFD(Huangqi Fuzheng Decoction) has the ability to suppress the expression of HIF-1αand VEGF in the best effective dose of improving the immune function,to provide evidence for the clinical application of HFD.Method Lewis lung cancer bearing mice were established and then randomly assigned into the following four groups(n=7,each group):model group,Huangqi Fuzheng Decoction(HFD) group,Cisplatin(DDP) group,HFD combined with DDP group.DDP group was treated with DDP 2 mg·Kg~(-1) intraperitoneally once every other day for 8 times;HFD group was treated with HFD 10 mL·Kg~(-1) orally once daily for 15 days;HFD plus DDP group adopted the same administration of HFD and DDP;Control group was treated with the same amount of normal sodium orally and/or intraperitoneally. The mice were sacrificed on the 15th day,stripping out the tumors tissiues and weighting.The tumor inhibition rate was calculated.We detected the expression level of HIF-1αand VEGF with IHC.Results The weight of the tumors in the model group were heavier than those of the HFD group(P<0.05).The weight of the tumors in DDP plus HFD group was lighter than those of other groups(P<0.05),The tumor inhibition rate is the highest in HFD and DDP treated group(P<0.05).The result of immunohistochemistry showed the expression of HIF-1αand VEGF in treated groups was significantly decreased when compared with the control group(P<0.05). Conclusion Huangqi Fuzheng Decoction could inhibit the growth of the tumor on Lewis lung cancer bearing mice.The mechanism may be correlated with the inhibition of HIF-1αand VEGF.